BAM15 50mg

Description

BAM15 is a mitochondrial uncoupler — a compound that short-circuits the proton gradient in the inner mitochondrial membrane, forcing cells to burn fuel for heat generation rather than ATP production. The result is dramatically increased caloric expenditure with no change in food intake, no central nervous system stimulation, and no increase in body temperature at therapeutic doses. This distinguishes BAM15 fundamentally from DNP: where DNP is a non-selective uncoupler with a narrow therapeutic window and genuine lethality risk, BAM15’s uncoupling activity is mitochondria-selective, self-limiting at physiological concentrations, and demonstrably safe in animal studies at doses producing significant fat loss. In obese mouse models, BAM15 reduced fat mass by over 30% in four weeks without any reduction in lean mass — a metabolic effect rarely seen with any intervention. At 50mg, research into human application is ongoing. For those working at the cutting edge of metabolic pharmacology, BAM15 represents a genuinely novel mechanism. Verified at 99%+ purity by Puralytix. Stack with dietary fat restriction and mild caloric deficit for maximum effect — BAM15’s uncoupling mechanism is most impactful when substrate availability is maintained but calories are controlled. The self-limiting nature of its uncoupling activity at physiological concentrations makes it safer than classical uncouplers at equivalent metabolic effect doses. Core temperature monitoring is advisable during initial use — a rise of more than 1°C above baseline warrants dose review.